Clinical trials for Tick-borne encephalitis

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Tick-borne encephalitis. For all clinical trials, go to clinical trials search

This list shows clinical trials for Tick-borne encephalitis

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Tick-borne encephalitis
Title Recruitment status Location
Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac Not recruiting United Kingdom
Tick-borne Encephalitis and Positive Borrelial Antibodies Recruiting Slovenia
New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly Recruiting Finland
New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly Recruiting Sweden
A Phase II, Open Label Trial of a Vaccine (FSME-IMMUN 0.5 mL) Against Tick-borne Encephalitis (TBE) for NIAID Workers Manipulating Tick Borne Encephalitis Virus (TBEV) in the Laboratory Recruiting United States
Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients Recruiting Austria
A Phase III, randomized, observer-blind, controlled, multi-center clinical study to evaluate the efficacy, safety and immunogenicity of one and two intramuscular doses of FLUAD versus control vaccines in unprimed healthy subjects aged between 6 and up to 72 months. Not Recruiting Belgium
A Phase III, randomized, observer-blind, controlled, multi-center clinical study to evaluate the efficacy, safety and immunogenicity of one and two intramuscular doses of FLUAD versus control vaccines in unprimed healthy subjects aged between 6 and up to 72 months. Not Recruiting Finland
A Phase III, randomized, observer-blind, controlled, multi-center clinical study to evaluate the efficacy, safety and immunogenicity of one and two intramuscular doses of FLUAD versus control vaccines in unprimed healthy subjects aged between 6 and up to 72 months. Not Recruiting Germany
A Phase III, randomized, observer-blind, controlled, multi-center clinical study to evaluate the efficacy, safety and immunogenicity of one and two intramuscular doses of FLUAD versus control vaccines in unprimed healthy subjects aged between 6 and up to 72 months. Not Recruiting Hungary

Page last reviewed: 09/12/2015

Next review due: 30/04/2018